| |
| |
|
| Insider
Information: |
Berkowitz Noah |
| Relationship: |
Chief Medical Officer |
| City: |
Parsippany |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
210,086 |
|
|
Indirect Shares
|
108,756 |
|
|
| Direct
Value |
$2,003,180 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
318,842 |
|
|
| Total
Value |
$2,003,180 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synvista Therapeutics Inc |
SYNI |
President & CEO, Direc... |
2007-11-01 |
146,634 |
2007-11-21 |
108,756 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Chief Medical Officer |
2024-03-18 |
63,452 |
2024-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARVN |
Arvinas Holding Company, ... |
Chief Medical Officer |
• – – |
2024-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
63,452 |
63,452 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-11-21 |
4 |
D |
$2.40 |
$7,200 |
I/I |
(3,000) |
108,756 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-11-01 |
4 |
D |
$2.41 |
$9,976 |
D/D |
(4,000) |
146,634 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-10-19 |
4 |
D |
$2.50 |
$7,540 |
I/I |
(3,000) |
111,756 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-10-02 |
4 |
D |
$2.77 |
$5,300 |
D/D |
(1,900) |
150,634 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-10-01 |
4 |
D |
$3.00 |
$6,430 |
D/D |
(2,100) |
152,534 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-09-17 |
4 |
D |
$3.05 |
$4,342 |
I/I |
(1,400) |
114,756 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-09-17 |
4 |
D |
$3.05 |
$9,923 |
D/D |
(3,200) |
154,634 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-09-14 |
4 |
D |
$3.22 |
$6,852 |
I/I |
(2,000) |
116,156 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-09-14 |
4 |
D |
$3.22 |
$14,385 |
D/D |
(4,200) |
157,834 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-09-13 |
4 |
D |
$3.45 |
$31,637 |
I/I |
(8,600) |
118,156 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-09-13 |
4 |
D |
$3.45 |
$61,057 |
D/D |
(16,600) |
162,034 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEO |
• • • |
2007-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
575,000 |
8,931,700 |
0 |
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEOOfficer |
• • • |
2006-07-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,337,800 |
|
- |
|
| SYNI |
Synvista Therapeutics Inc |
President & CEOOfficer |
• • • |
2006-07-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,506,700 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
